SEBI Circulars (1732)
Securities and Exchange Board of India circulars including regulatory frameworks, policy updates, compliance guidelines, enforcement actions, and market conduct rules.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SEBI issues a completion order confirming the execution of Recovery Certificate No. 5552 of 2022 against Mr. S Rajaganesh in the matter of … | |||||||||||||||
SEBI issues a completion order confirming the execution of Recovery Certificate No. 5552 of 2022 against Mr. S Rajaganesh in the matter of SMS Techsoft (India) Ltd., marking the conclusion of recovery proceedings.
| |||||||||||||||
SEBI issues a prohibitory order under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals Limited, restricting … | |||||||||||||||
SEBI issues a prohibitory order under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals Limited, restricting withdrawal of funds from bank and demat accounts to recover outstanding dues.
| |||||||||||||||
SEBI issues a Release Order discharging Recovery Certificate No. 5552 of 2022 against Mr. S Rajaganesh in the matter of SMS Techsoft (India) … | |||||||||||||||
SEBI issues a Release Order discharging Recovery Certificate No. 5552 of 2022 against Mr. S Rajaganesh in the matter of SMS Techsoft (India) Ltd., signifying the release of attached assets and conclusion of recovery proceedings.
| |||||||||||||||
SEBI issues completion certificate for Recovery Certificate No. 8713 of 2025 dated April 25, 2025 against Vikas Lifecare Limited (PAN: … | |||||||||||||||
SEBI issues completion certificate for Recovery Certificate No. 8713 of 2025 dated April 25, 2025 against Vikas Lifecare Limited (PAN: AADCA5571A), indicating recovery dues have been satisfied.
| |||||||||||||||
SEBI issued a Notice of Demand under Recovery Certificate No. 9053 of 2026 dated February 27, 2026, against Prerna Sharma, a Research … | |||||||||||||||
SEBI issued a Notice of Demand under Recovery Certificate No. 9053 of 2026 dated February 27, 2026, against Prerna Sharma, a Research Analyst designated as a defaulter, for recovery of dues.
| |||||||||||||||
SEBI issues a release order for Vikas Lifecare Limited (PAN: AADCA5571A) in connection with Recovery Certificate No. 8713 of 2025, releasing … | |||||||||||||||
SEBI issues a release order for Vikas Lifecare Limited (PAN: AADCA5571A) in connection with Recovery Certificate No. 8713 of 2025, releasing attached assets following satisfaction of recovery dues.
| |||||||||||||||
SEBI revises Chapter IX of the NCS Master Circular to align third-party reviewer/certifier requirements for green debt securities with those … | |||||||||||||||
SEBI revises Chapter IX of the NCS Master Circular to align third-party reviewer/certifier requirements for green debt securities with those applicable to social bonds, sustainability bonds, and sustainability-linked bonds.
| |||||||||||||||
SEBI issues a completion certificate for Recovery Certificate No. 6648 of 2023 against Sadanand Prayag Mishra (PAN: AFVPM2400E) in the … | |||||||||||||||
SEBI issues a completion certificate for Recovery Certificate No. 6648 of 2023 against Sadanand Prayag Mishra (PAN: AFVPM2400E) in the matter of Shreekrishna Biotech Limited, signifying successful recovery of dues.
| |||||||||||||||
SEBI issues a completion certificate confirming that Recovery Certificate No. 7930 of 2024 against Restock Research (Proprietor: Raj Kumar … | |||||||||||||||
SEBI issues a completion certificate confirming that Recovery Certificate No. 7930 of 2024 against Restock Research (Proprietor: Raj Kumar Kushwah, PAN: BWZPK7725C) has been fully satisfied.
| |||||||||||||||
SEBI issues enforcement order against Arcotech Limited and 13 related entities for alleged fund diversion of Rs.14.15 crores, fictitious … | |||||||||||||||
SEBI issues enforcement order against Arcotech Limited and 13 related entities for alleged fund diversion of Rs.14.15 crores, fictitious transactions, and misrepresentation of financial statements across FY 2016-17 to 2020-21.
| |||||||||||||||